Traduction de «Délit contre la défense nationale » (Français → Anglais) :

I am asking you, as Minister of National Defence, not only to address me on what is being done about the rise in suicides in National Defence but also to cooperate to ensure that something is done about developing a national policy for the prevention of suicide.

(Return tabled) Question No. 473 Hon. Ujjal Dosanjh: With regard to reports that Canadian soldiers witnessed Afghan children being sexually abused by members of the Afghan National Police or the Afghan National Army: (a) were any complaints or reports filed with either the Canadian Forces, Military Police, Department of National Defence, or Department of Foreign Affairs alleging that children were being abused; (b) when were these complaints or reports filed; (c) what actions were taken to address these complaints or reports; (d) when was the Minister of National Defence or his office informed of the existence of these complaints or r ...[+++]eports; (e) what instructions were given by the Minister of National Defence or his office with regard to these complaints or reports, and when; (f) when did the Minister of National Defence first receive a briefing on this issue; (g) when were briefing notes first written by either the Minister’s staff, the Department of National Defence, the Department of Foreign Affairs, the Canadian Forces, or the Military Police; (h) were the Canadian Forces or Military Police ever instructed not to report incidents of child sexual abuse and, if so, when; (i) were the Canadian Forces or Military Police ever instructed not to intervene or prevent incidents of child sexual abuse if they witnessed them and, if so, when; and (j) when were the Canadian Forces and Military Police explicitly instructed to report or prevent such incidents?

That, in light of the recent incident of a Russian military aircraft approaching Canada's Airspace, the Standing Committee on National Defence receive a briefing from Department of National Defence officials on: the current resources available to meet such threats, the role of NORAD, military communications between the Canadian and Russian Governments, and the detailed defence strategy to defend against similar future threats.

However, in cases duly specified in this Directive it should be possible to request a proportionate and cost-based fee without prejudice to national legislation on tax or social matters or any obligations on the electronic money issuer under other relevant Community or national legislation, such as anti-money laundering and anti-terrorist financing rules, any action targeting the freezing of funds or any specific measure linked to the prevention and investigation of crimes.

6. This Directive shall not apply to activities the main purpose of which is to serve national defence or international security nor to activities the sole purpose of which is to protect from natural disasters.

With reference to the side effects experienced by those taking the anti-malarial drug mefloquine (Lariam): (a) provide a detailed update on the clinical study of mefloquine (Lariam) announced by the Department of National Defence in 1997, including trial design, subject inclusion/exclusion criteria, numbers of study subjects recruited to date and participating centres; (b) have reviews been undertaken of the side effects experienced by the Australian, British and Dutch forces, if so what were the results and recommendations, and what ...[+++] steps have been undertaken to implement these recommendations; (c) with regard to the mefloquine (Lariam) used for the prophylaxis of Canadian troops deployed to Somalia, what was the nature of the Department of Health's Health Protection Branch investigations in October 1997 into the failure of the manufacturer to properly supervise and ensure compliance with the Lariam safety monitoring study and the failure of the Department of National Defence to comply with its obligations under the safety monitoring study; (d) with regard to the mefloquine (Lariam) used for the prophylaxis of Canadian troops deployed to Somalia, what was the outcome of the Department of Health's Health Protection Branch investigations in October 1997 into the failure of the manufacturer to properly supervise and ensure compliance with the Lariam safety monitoring study and the failure of the Department of National Defence to comply with its obligations under the safety monitoring study; (e) what is the date of the insert in the mefloquine (Lariam) package used in Canada today; (f) what is the date of the product monograph for mefloquine (Lariam) used in Canada today; (g) have reviews been undertaken of the insert in the mefloquine (Lariam) package and the prescribing information used in Australia, if so what were the results and recommendations of the reviews, and what steps have been taken to implement the recommendations; (h) have reviews been undertaken ...